UnitedHealth Group Incorporated (NYSE:UNH) Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

UnitedHealth Group Incorporated (NYSE UNH) traded down $0.95 on Wednesday, hitting $211.71. The stock had a trading volume of 1,993,900 shares, compared to its average volume of 3,126,724. The company has a market cap of $206,081.91, a P/E ratio of 22.15, a PEG ratio of 1.58 and a beta of 0.64. UnitedHealth Group Incorporated has a 52 week low of $148.56 and a 52 week high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.17 EPS. research analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is 33.26%.

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-director-kenneth-irwin-shine-sells-457-shares/1705739.html.

Large investors have recently made changes to their positions in the stock. Marshall Wace LLP boosted its stake in UnitedHealth Group by 441.4% during the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after purchasing an additional 11,361 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares during the period. American Century Companies Inc. boosted its stake in UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after purchasing an additional 681,111 shares during the period. Essex Financial Services Inc. boosted its stake in UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after purchasing an additional 967 shares during the period. Finally, Factory Mutual Insurance Co. boosted its stake in UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after purchasing an additional 72,000 shares during the period. Hedge funds and other institutional investors own 86.00% of the company’s stock.

A number of research firms have recently commented on UNH. Credit Suisse Group began coverage on UnitedHealth Group in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price objective on the stock. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Mizuho reissued a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, October 24th. Argus boosted their price objective on UnitedHealth Group from $215.00 to $230.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $219.00 price objective (up previously from $210.00) on shares of UnitedHealth Group in a research note on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $216.65.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.